Search Results - "Di Giacomo, Filomena"
-
1
Convergent Mutations and Kinase Fusions Lead to Oncogenic STAT3 Activation in Anaplastic Large Cell Lymphoma
Published in Cancer cell (13-04-2015)“…A systematic characterization of the genetic alterations driving ALCLs has not been performed. By integrating massive sequencing strategies, we provide a…”
Get full text
Journal Article -
2
Tailoring CD19xCD3-DART exposure enhances T-cells to eradication of B-cell neoplasms
Published in Oncoimmunology (03-04-2018)“…Many patients with B-cell malignancies can be successfully treated, although tumor eradication is rarely achieved. T-cell-directed killing of tumor cells using…”
Get full text
Journal Article -
3
Rapid identification of BCR/ABL1‐like acute lymphoblastic leukaemia patients using a predictive statistical model based on quantitative real time‐polymerase chain reaction: clinical, prognostic and therapeutic implications
Published in British journal of haematology (01-06-2018)“…Summary BCR/ABL1‐like acute lymphoblastic leukaemia (ALL) is a subgroup of B‐lineage acute lymphoblastic leukaemia that occurs within cases without recurrent…”
Get full text
Journal Article -
4
Cell of origin markers identify different prognostic subgroups of lung adenocarcinoma
Published in Human pathology (01-05-2018)“…Strong prognostic markers able to stratify lung adenocarcinoma (ADC) patients are lacking. We evaluated whether a six-immunohistochemical markers panel (TTF1,…”
Get full text
Journal Article -
5
RNA sequencing unravels the genetics of refractory/relapsed T-cell acute lymphoblastic leukemia. Prognostic and therapeutic implications
Published in Haematologica (Roma) (01-08-2016)“…Despite therapeutic improvements, a sizable number of patients with T-cell acute lymphoblastic leukemia still have a poor outcome. To unravel the genomic…”
Get full text
Journal Article -
6
Convergent Mutations and Kinase Fusions Lead to Oncogenic STAT3 Activation in Anaplastic Large Cell Lymphoma
Published in Cancer cell (11-05-2015)Get full text
Journal Article -
7
Prognostic and therapeutic role of targetable lesions in B-lineage acute lymphoblastic leukemia without recurrent fusion genes
Published in Oncotarget (22-03-2016)“…To shed light into the molecular bases of B-lineage acute lymphoblastic leukemia lacking known fusion transcripts, i.e. BCR-ABL1, ETV6-RUNX1, E2A-PBX1, and MLL…”
Get full text
Journal Article -
8
Endothelial cell–leukemia interactions remodel drug responses, uncovering T-ALL vulnerabilities
Published in Blood (02-02-2023)“…•We identified active compounds in a library of 22 T-ALL PDX and discovered public and private vulnerabilities•Interacting ECs and T-ALL underwent reciprocal…”
Get full text
Journal Article -
9
A Predictive Endothelial-Leukemia Pre-Clinical Platform to Uncover Drug Vulnerabilities for Personalized Treatments
Published in Blood (23-11-2021)“…Background. T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive disease with few innovative treatment options. This is also contributed by the lack of…”
Get full text
Journal Article -
10
-
11
Excess of NPM-ALK oncogenic signaling promotes cellular apoptosis and drug dependency
Published in Oncogene (21-07-2016)“…Most of the anaplastic large-cell lymphoma (ALCL) cases carry the t(2;5; p23;q35) that produces the fusion protein NPM-ALK (nucleophosmin-anaplastic lymphoma…”
Get full text
Journal Article -
12
Rapid identification of BCR / ABL 1 ‐like acute lymphoblastic leukaemia patients using a predictive statistical model based on quantitative real time‐polymerase chain reaction: clinical, prognostic and therapeutic implications
Published in British journal of haematology (01-06-2018)“…BCR / ABL 1 ‐like acute lymphoblastic leukaemia ( ALL ) is a subgroup of B‐lineage acute lymphoblastic leukaemia that occurs within cases without recurrent…”
Get full text
Journal Article -
13
Generation and Application of T-Cell Lymphoma Patient Derived Tumor Xenograft Models
Published in Blood (08-12-2017)“…Introduction: Although pivotal “driver mutations” have been described in T-cell lymphomas (T-NHL), targetable dependences are lacking for many entities. As…”
Get full text
Journal Article -
14
Abstract 131: ALK oncogene regulates epithelial-mesenchymal transition (EMT) in ALK-rearranged non-small cell lung carcinoma through repression of the epithelial splicing regulatory proteins 1 and 2 (ESRP1 and ESRP2)
Published in Cancer research (Chicago, Ill.) (01-08-2015)“…A subset of Non-Small Cell Lung Carcinoma (NSCLC) carries chromosomal rearrangements involving the Anaplastic Lymphoma Kinase (ALK) gene. More frequently ALK…”
Get full text
Journal Article -
15
Efficacy of a Cancer Vaccine against ALK-Rearranged Lung Tumors
Published in Cancer immunology research (01-12-2015)“…Non-small cell lung cancer (NSCLC) harboring chromosomal rearrangements of the anaplastic lymphoma kinase (ALK) gene is treated with ALK tyrosine kinase…”
Get more information
Journal Article -
16
The Pro-Tumorigenic Vascular Niche Sustains the T-Cell Acute Lymphoblastic Leukemia Phenotype and Fosters Resistance to Therapy
Published in Blood (02-12-2016)“…Introduction. T-cell acute lymphoblastic leukemia (T-ALL) is a genetically heterogeneous malignancy associated with a high risk of treatment failure. Efforts…”
Get full text
Journal Article -
17
Convergent Mutations and New Kinase Fusions Lead to Oncogenic STAT3 Activation in Anaplastic Large Cell Lymphoma
Published in Blood (06-12-2014)“…Introduction. If the role of ALK chimeras is well known in the pathogenesis of ALK+ Anaplastic Large Cell Lymphoma (ALCL), the mechanisms leading to the…”
Get full text
Journal Article -
18
ALK Signaling and Target Therapy in Anaplastic Large Cell Lymphoma
Published in Frontiers in oncology (2012)“…The discovery by Morris et al. (1994) of the genes contributing to the t(2;5)(p23;q35) translocation has laid the foundation for a molecular based recognition…”
Get full text
Journal Article